Débora Ayres Saraiva

Débora Ayres Saraiva

Auto-generated profile, based on publicly available information

Débora Ayres Saraiva

Programa de Pós-graduação em Endocrinologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2020 in Thyroid®
Verified
Journal Article
Closed access
NMNathalie Silva de Morais
Nathalie Silva de Morais
DSDébora Ayres Saraiva
Débora Ayres Saraiva
CCCarolina Corcino
Carolina Corcino
TBTatiana Berbara
Tatiana Berbara
ASAnnie Schtscherbyna
Annie Schtscherbyna
PTPatrícia De Fátima Dos Santos Teixeira
Patrícia De Fátima Dos Santos Teixeira
Background: Insufficient or excessive iodine intake during gestation may compromise adaptive mechanisms in maternal thyroid function and lead to adverse pregnancy outcomes. In this context, we aimed to study the effects of maternal iodine status in the first and third trimesters of gestation on obstetric and neonatal outcomes in an iodine-sufficient population in Rio de Janeiro, Brazil. Methods: A total of 214 pregnant women in the first trimester of gestation were enrolled and prospectively followed until delivery between 2014 and 2017. All participants were ≥18 and ≤35 years, had a spontaneous single pregnancy, and had no history of thyroid or other chronic diseases, nor were they taking iodine-containing supplements at enrollment. In the first trimester, we obtained clinical information and determined thyroid function and the urinary iodine concentration (UIC) of the participants. Thyroid function and UIC were reassessed in the third trimester. Iodine status was determined by the median of UIC obtained from six urine spot samples by the inductively coupled plasma mass spectrometry method. Pregnancy and neonatal outcomes and delivery information were obtained from medical records. Results: The median UIC in the whole population was 219.7 μg/L. The prevalence of UIC <150 μg/L was 17.2%, and 38.7% had UIC ≥250 μg/L. Gestational diabetes (GDM) was higher in the group with UIC 250–499 μg/L ( n = 77) compared with the group with UIC 150–249 μg/L ( n = 94) (20.3% vs. 9.7%, p < 0.05). Ultimately, UIC ≥250 μg/L was an independent risk factors for GDM (relative risk [RR] = 2.9 [confidence interval, CI = 1.1–7.46], p = 0.027) and hypertensive disorders of pregnancy (HDP) (RR = 4.6 [CI = 1.1–18.0], p = 0.029). Among 196 live-born newborns, lower birth length was observed in infants whose mothers had UIC <150μg/L ( n = 37) in the first trimester compared with those with UIC 150–249 μg/L ( n = 86) (median interquartile range: 48.0 [2.2] vs. 49.0 [4.0] cm, p = 0.01). Maternal UIC <150 μg/L was negatively associated with birth length of newborns (Exp (B) = 0.33 [CI = 0.1–0.9], p = 0.03). Conclusions: In a population whose median iodine intake is sufficient, extensive individual variation occurs. Such abnormalities are associated with increased GDM and HDP when UIC is ≥250 μg/L, and lower infant birth length when UIC is <150 μg/L.

1 September 2018 in Nutrition
Verified
Journal Article
Closed access
PDF file
DSDébora Ayres Saraiva
Débora Ayres Saraiva
NMNathalie Anne de Oliveira e Silva de Morais
Nathalie Anne de Oliveira e Silva de Morais
CCCarolina Martins Corcino
Carolina Martins Corcino
TBTatiana Martins Benvenuto Louro Berbara
Tatiana Martins Benvenuto Louro Berbara
ASAnnie Schtscherbyna
Annie Schtscherbyna
PTPatrícia de Fátima dos Santos Teixeira
Patrícia de Fátima dos Santos Teixeira

18 March 2020 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
TBTatiana Martins Benvenuto Louro Berbara
Tatiana Martins Benvenuto Louro Berbara
NMNathalie Silva de Morais
Nathalie Silva de Morais
DSDébora Ayres Saraiva
Débora Ayres Saraiva
CCCarolina Martins Corcino
Carolina Martins Corcino
ASAnnie Schtscherbyna
Annie Schtscherbyna
MVMario Vaisman
Mario Vaisman
Maternal hypothyroidism during pregnancy may lead to adverse outcomes. Recently published guidelines by the American Thyroid Association (ATA) do not advocate for universal screening but recommend a case-finding approach in high-risk pregnant women. The present study aims to evaluate the accuracy of this approach in identifying women with thyroid dysfunction during early pregnancy. This is a multiple-center, cross-sectional study. Three hundred and one pregnant women were enrolled. Anamnesis and a physical examination were performed to detect which women fulfilled the criteria to undergo laboratory screening of thyroid dysfunction, according to the ATA's 2017 guidelines. The Zulewski's validated clinical score was applied to assess signs and symptoms of hypothyroidism. Serum levels of thyrotropin (TSH), free thyroxine (FT4), anti-thyroperoxidase (TPO-Ab), and anti-thyroglobulin (Tg-Ab) antibodies were determined. Two hundred and thirty one women (78%) were classified as high risk, and 65 (22%) were classified as low risk for thyroid dysfunction. Regarding the clinical score, 75 patients (31.2%) presented mild symptoms that were compatible with SCH, of which 22 (7.4%) had symptoms as the only risk factor for thyroid disease. 17 patients (5.7%) had SCH, of which 10 (58.8%) belonged to the high-risk group, and 7 (41.2%) belonged to the low-risk group. OH was found in 4 patients (1.4%): 3 (75%) in the high-risk group and 1 (25%) in the low-risk group. The ATA's proposed screening criteria were not accurate in the diagnosis of thyroid dysfunction in pregnancy. Testing only the high-risk pregnant women would miss approximately 40% of all hypothyroid patients.

1 January 2025 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
ASAnnie Schtscherbyna
Annie Schtscherbyna
DSDébora Ayres Saraiva
Débora Ayres Saraiva
NMNathalie Silva de Morais
Nathalie Silva de Morais
CCCarolina Martins Corcino
Carolina Martins Corcino
TBTatiana Martins Benvenuto Louro Berbara
Tatiana Martins Benvenuto Louro Berbara
PHPaula Martins Horta
Paula Martins Horta
Objective: Conditions related to iodine status (IS) during pregnancy should be addressed to improve public health strategies. The aim of this study was to analyze the relationship between diet quality (DQ), assessed by the adapted Healthy Eating Index-2015 (HEI-2015), and IS in pregnant women from a Brazilian coastal state where public health policies assure iodine-fortified table salt in concentrations ranging from 15 to 45 mg/kg. Subjects and methods: In a cross-sectional study, 199 participants were evaluated on three different [...] ABSTRACT Objective: Conditions related to iodine status (IS) during pregnancy should be addressed to improve public health strategies. The aim of this study was to analyze the relationship between diet quality (DQ), assessed by the adapted Healthy Eating Index-2015 (HEI-2015), and IS in pregnant women from a Brazilian coastal state where public health policies assure iodine-fortified table salt in concentrations ranging from 15 to 45 mg/kg. Subjects and methods: In a cross-sectional study, 199 participants were evaluated on three different